For the Quarter Ending March 2026
Famotidine Prices in APAC
- In China, the Famotidine Price Index fell by 11.46% quarter-over-quarter, reflecting weaker post-tender demand conditions.
- The average Famotidine price for the quarter was approximately USD 57399/MT on CFR Shanghai import statistics.
- Firm restocking compressed bonded inventory cycles, supporting the Famotidine Spot Price and tightening visible supply windows.
- Logistics constraints raised container rates, influencing the Famotidine Price Forecast and lifting landed cost pressure.
- Exchange rate shifts and freight spikes drove the short-term Famotidine Production Cost Trend higher for importers.
- Domestic hospital tender timing shaped the Famotidine Demand Outlook, moderating buying momentum after initial restocking.
- Traders adjusted offers lower as the Famotidine Price Index loosened amid comfortable arrivals and steady production.
- Market sentiment remained cautious; sellers used competitive pricing to clear volumes, limiting any sustained upside.
Why did the price of Famotidine change in March 2026 in APAC?
- Higher India-to-Shanghai container freight lifted landed costs, transmitting directly into import CIF and CFR offers.
- Brisk hospital restocking accelerated offtake, shortening bonded inventory cycles and reducing visible supply buffers rapidly.
- The modest Yuan movement moderated dollar cost impact, while steady export production kept physical availability stable.
Famotidine Prices in North America
- In the USA, the Famotidine Price Index fell by 11.45% quarter-over-quarter, due to abundant imports.
- The average Famotidine price for the quarter was approximately USD 57539.67/MT, reflecting supplier concessions globally.
- Prompt logistical delays and tighter lots pushed Famotidine Spot Price and Famotidine Price Index higher.
- Near-term Famotidine Price Forecast suggests mild April upside as buyers replenish inventories ahead of tenders.
- Famotidine Production Cost Trend saw stable feedstock pricing offset by rising freight and insurance premiums.
- Famotidine Demand Outlook remains steady with seasonal OTC increases and hospital procurement supporting consistent offtake.
- Competitive export offers from India preserved availability, keeping CFR offers competitive and distributor margins pressured.
- Temporary pauses at two Indian plants tightened prompt supply, prompting U.S. buyers to accelerate restocking.
Why did the price of Famotidine change in March 2026 in North America?
- Regulatory pauses at Indian manufacturers reduced exports, tightening U.S. import availability and elevating prompt quotations.
- A sharp freight rise on the India-New York Lane increased landed costs, pressuring CFR offers.
- U.S. buyers accelerated purchases to rebuild inventories ahead of mid-April hospital tenders, lifting short-term demand.
Famotidine Prices in Europe
- In Germany, the Famotidine Price Index declined quarter-over-quarter, reflecting abundant imports and competitive supplier pricing.
- Famotidine Spot Price strengthened in March as temporary shipping delays and tighter lot availability reduced immediate supply.
- The Famotidine Production Cost Trend remained stable, with steady feedstock pricing partially offset by higher freight and insurance costs.
- The Famotidine Demand Outlook remained steady, supported by consistent hospital procurement and seasonal OTC demand.
- The Famotidine Price Forecast indicates mild near-term upside as buyers rebuild inventories ahead of upcoming tenders.
- Inventory levels across European distributors remained adequate, though slight tightening occurred due to delayed arrivals.
- Import flows from India remained competitive, though occasional plant pauses temporarily reduced prompt availability.
- Suppliers maintained aggressive export pricing strategies, keeping CFR offers competitive despite logistics pressures.
Why did the price of Famotidine change in March 2026 in Europe?
- Temporary manufacturing pauses in India reduced export availability, tightening European import supply.
- Rising freight and insurance costs increased landed import prices, pushing CFR quotations higher.
- Strong hospital procurement and restocking ahead of tenders increased short-term buying activity.
For the Quarter Ending December 2025
Famotidine Prices in APAC
- In China, the Famotidine Price Index fell by 5.25% quarter-over-quarter, reflecting Indian oversupply and softer import demand.
- The average Famotidine price for the quarter was approximately USD 70553.33/MT, reported across CFR Shanghai shipments.
- Famotidine Spot Price weakened while the Price Index eased as port inventories increased and buyers delayed replenishment.
- Famotidine Price Forecast projects mild recovery early next year as restocking offsets excess supply, per shipping schedules.
- Famotidine Production Cost Trend remained benign with stable energy and freight components, limiting upward pressure on the Price Index.
- Famotidine Demand Outlook is muted; hospital tenders and OTC sales provided modest support during year-end procurement cycles.
- Famotidine Price Index volatility moderated as logistics normalized, enabling distributors to clear stocks without aggressive discounting.
- Indian export flows and stable Chinese production meant traders adjusted offers, influencing near-term Famotidine Spot Price and liquidity.
Why did the price of Famotidine change in December 2025 in APAC?
- Increased Indian and Spanish arrivals raised Shanghai inventories, easing immediate supply tightness and pressuring spot margins.
- Year-end hospital tender activity induced targeted restocking, mildly lifting demand while overall buyer urgency remained restrained.
- Stable freight and energy costs limited landed cost increases, so logistical predictability failed to support stronger price gains.
Famotidine Prices in North America
- In the USA, the Famotidine Price Index fell by 5.23% quarter-over-quarter, driven by surplus exports.
- The average Famotidine price for the quarter was approximately USD 70660.00/MT, reflecting moderated CFR levels.
- Famotidine Spot Price activity remained thin as buyers delayed purchases, reducing immediate volumes and pressure.
- Famotidine Price Forecast indicates near-term modest volatility with limited upside due to balanced supply conditions.
- Famotidine Production Cost Trend showed easing as freight declines and feedstock stability lowered landed pressure.
- Famotidine Demand Outlook remains cautious with tender delays and substitution limiting procurement and restraining the offtake.
- Inventories elevated and steady export interest pressured the Famotidine Price Index, constraining immediate recovery momentum.
- Major manufacturers reported normal operating rates, supporting exports and preventing acute shortages in US markets.
Why did the price of Famotidine change in December 2025 in North America?
- Year-end replenishment by wholesalers increased spot buying, supporting prices despite earlier export-driven oversupply and discounting.
- Freight cost reductions trimmed landed costs, but exporters withheld discounts, protecting margins and limiting pass-through.
- Procurement caution and tender postponements delayed large orders, keeping demand subdued while inventories stayed elevated.
Famotidine Prices in Europe
- In Europe, the Famotidine Price Index declined quarter-over-quarter, broadly tracking global oversupply trends and moderated regional demand.
- Famotidine Spot Price activity remained subdued as buyers maintained cautious procurement strategies, delaying large-volume purchases toward the end of the quarter.
- Famotidine Price Forecast suggests limited near-term upside, with balanced supply conditions and sufficient inventories expected to cap strong recovery.
- Famotidine Production Cost Trend showed slight easing, supported by stable feedstock prices and improved freight conditions, reducing overall cost pressures.
- Famotidine Demand Outlook remained conservative, as hospital tenders progressed slowly and substitution trends constrained incremental consumption.
- Elevated inventory levels across key distribution hubs weighed on the Famotidine Price Index, limiting upward momentum despite steady downstream requirements.
- Regional suppliers maintained consistent operating rates, ensuring adequate availability and preventing supply-side disruptions.
- Trade flows from Asia and intra-European distribution networks contributed to competitive pricing, influencing spot liquidity and short-term market sentiment.
Why did the price of Famotidine change in December 2025 in Europe?
- Year-end restocking by select distributors provided marginal support to spot prices, though overall purchasing activity remained restrained.
- Improved freight conditions reduced landed costs, but suppliers avoided aggressive price reductions, maintaining margin stability.
- Delayed procurement cycles and cautious tender activity kept demand muted, while existing inventories continued to meet most short-term requirements.
For the Quarter Ending September 2025
Famotidine Prices in North America
- In United States, the Famotidine Price Index rose quarter-over-quarter in Q3 2025, driven by significant increases in production costs.
- Famotidine production costs increased in Q3 2025, due to a 2.6% year-over-year PPI rise in August 2025 and higher energy prices.
- Demand for Famotidine faced mixed signals, with robust retail sales (5.42% YoY in September 2025) offset by declining consumer confidence.
- The Famotidine Price Index experienced upward pressure, reflecting a 3.0% year-over-year CPI increase in September 2025 and rising input expenses.
- Overall manufacturing activity contracted in Q3 2025, and broader economic conditions deteriorated, impacting the chemical market.
- US natural gas prices strengthened year-over-year in Q3 2025, raising feedstock and wholesale power costs for chemical production.
- Chemical inventories tightened in Q3 2025 due to accelerated destocking, while US chemical exports and imports decreased in July 2025.
- A 4.3% unemployment rate in September 2025 supported consumer disposable income, positively influencing demand for healthcare products.
Why did the price of Famotidine change in September 2025 in North America?
- Rising production costs, with a 2.6% YoY PPI increase in August 2025, impacted Famotidine pricing.
- Increased energy and raw material expenses, as US natural gas prices strengthened in Q3 2025, raised costs.
- Mixed demand signals, including 5.42% YoY retail sales in September 2025, influenced market.
Famotidine Prices in APAC
- In China, the Famotidine Price Index fell quarter-over-quarter in Q3 2025, driven by declining production costs and elevated industry overcapacity.
- Famotidine production costs decreased as the Producer Price Index declined 2.3% in September 2025 and international crude oil prices weakened.
- Demand for Famotidine was supported by a 6.5% rise in industrial production and 3.0% growth in retail sales in September 2025.
- However, the Manufacturing Index was contracting in September 2025, and consumer confidence was 89.6, tempering overall demand.
- Industry overcapacity in the broader chemical sector remained elevated in Q3 2025, following significant capacity additions.
- China's API market share expanded in Q3 2025, bolstered by government incentives and surging high-tech manufacturing output.
- Healthcare spending strengthened in China in 2025, supported by increased government funding for public health services.
- International crude oil prices gradually weakened in Q3 2025, reducing energy and feedstock costs for Famotidine production.
Why did the price of Famotidine change in September 2025 in APAC?
- The Producer Price Index declined 2.3% in September 2025, and international crude oil prices weakened, lowering production costs.
- Elevated industry overcapacity and significantly increased chemical production capacity in Q3 2025 created downward price pressure.
- A contracting Manufacturing Index in September 2025 and consumer confidence at 89.6 tempered demand, influencing prices.
Famotidine Prices in Europe
- In Germany, Famotidine Price Index remained stable in Q3 2025, balancing demand and cost pressures.
- Famotidine production costs saw downward pressure from a 1.7% decline in producer prices in September 2025.
- Elevated energy and raw material costs, plus high carbon allowance costs, challenged Famotidine production in Q3 2025.
- Famotidine demand outlook was supported by strengthening pharmaceutical demand and stable 0.2% retail sales in September 2025.
- Consumer purchasing power for OTC Famotidine was impacted by a 2.4% CPI increase, despite stable 6.3% unemployment.
- German industrial production declined 1.0% in September 2025, reflecting a contracting manufacturing index in Q3 2025.
- European natural gas prices trended downwards through September 2025, though German prices inched up.
- US tariffs significantly impacted German pharmaceutical exports in July 2025, affecting trade flows.
- The Famotidine Price Index forecast suggests continued stability, influenced by ongoing demand and cost dynamics.
Why did the price of Famotidine change in September 2025 in Europe?
- Strengthening pharmaceutical demand in Q3 2025 supported consumption, despite a 2.4% CPI increase.
- Producer prices declined 1.7% in September 2025, but chemical energy and raw material costs remained elevated.
- German industrial production fell 1.0% in September 2025; US tariffs impacted exports.
